• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MicroRNA-7 通过靶向 FAK 表达抑制乳腺癌细胞的上皮间质转化和转移。

MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.

机构信息

Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, PR China.

出版信息

PLoS One. 2012;7(8):e41523. doi: 10.1371/journal.pone.0041523. Epub 2012 Aug 2.

DOI:10.1371/journal.pone.0041523
PMID:22876288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3410899/
Abstract

Focal adhesion kinase (FAK) is an important mediator of extracellular matrix integrin signaling, cell motility, cell proliferation and cell survival. Increased FAK expression is observed in a variety of solid human tumors and increased FAK expression and activity frequently correlate with metastatic disease and poor prognosis. Herein we identify miR-7 as a direct regulator of FAK expression. miR-7 expression is decreased in malignant versus normal breast tissue and its expression correlates inversely with metastasis in human breast cancer patients. Forced expression of miR-7 produced increased E-CADHERIN and decreased FIBRONECTIN and VIMENTIN expression in breast cancer cells. The levels of miR-7 expression was positively correlated with E-CADHERIN mRNA and negatively correlated with VIMENTIN mRNA levels in breast cancer samples. Forced expression of miR-7 in aggressive breast cancer cell lines suppressed tumor cell monolayer proliferation, anchorage independent growth, three-dimensional growth in Matrigel, migration and invasion. Conversely, inhibition of miR-7 in the HBL-100 mammary epithelial cell line promoted cell proliferation and anchorage independent growth. Rescue of FAK expression reversed miR-7 suppression of migration and invasion. miR-7 also inhibited primary breast tumor development, local invasion and metastatic colonization of breast cancer xenografts. Thus, miR-7 expression is decreased in metastatic breast cancer, correlates with the level of epithelial differentiation of the tumor and inhibits metastatic progression.

摘要

黏着斑激酶(FAK)是细胞外基质整合素信号、细胞迁移、细胞增殖和细胞存活的重要介质。在各种实体人类肿瘤中观察到 FAK 表达增加,并且 FAK 表达和活性的增加经常与转移疾病和预后不良相关。在此,我们确定 miR-7 是 FAK 表达的直接调节因子。miR-7 在恶性与正常乳腺组织中的表达降低,其表达与人类乳腺癌患者的转移呈负相关。在乳腺癌细胞中强制表达 miR-7 可增加 E-CADHERIN 的表达,并降低 FIBRONECTIN 和 VIMENTIN 的表达。在乳腺癌样本中,miR-7 的表达水平与 E-CADHERIN mRNA 呈正相关,与 VIMENTIN mRNA 水平呈负相关。在侵袭性乳腺癌细胞系中强制表达 miR-7 可抑制肿瘤细胞单层增殖、锚定非依赖性生长、Matrigel 中的三维生长、迁移和侵袭。相反,在 HBL-100 乳腺上皮细胞系中抑制 miR-7 可促进细胞增殖和锚定非依赖性生长。FAK 表达的挽救逆转了 miR-7 对迁移和侵袭的抑制作用。miR-7 还抑制了原发性乳腺癌的发展、局部侵袭和乳腺癌异种移植物的转移性定植。因此,miR-7 在转移性乳腺癌中的表达降低,与肿瘤上皮分化的水平相关,并抑制转移性进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/0ad3d1eca6d2/pone.0041523.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/3e421fa53e9f/pone.0041523.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/ef7dc50f7d08/pone.0041523.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/2232fd85ae6e/pone.0041523.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/317b86701b57/pone.0041523.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/645bb41692ef/pone.0041523.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/05c45acf227e/pone.0041523.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/0ad3d1eca6d2/pone.0041523.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/3e421fa53e9f/pone.0041523.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/ef7dc50f7d08/pone.0041523.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/2232fd85ae6e/pone.0041523.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/317b86701b57/pone.0041523.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/645bb41692ef/pone.0041523.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/05c45acf227e/pone.0041523.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0f/3410899/0ad3d1eca6d2/pone.0041523.g007.jpg

相似文献

1
MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.MicroRNA-7 通过靶向 FAK 表达抑制乳腺癌细胞的上皮间质转化和转移。
PLoS One. 2012;7(8):e41523. doi: 10.1371/journal.pone.0041523. Epub 2012 Aug 2.
2
MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.微小RNA-30a通过靶向乳腺癌中的Slug增加紧密连接蛋白表达,从而抑制上皮-间质转化和转移。
Oncotarget. 2016 Mar 29;7(13):16462-78. doi: 10.18632/oncotarget.7656.
3
miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.miR-655 通过靶向三阴性乳腺癌中的 Prrx1 抑制上皮-间充质转化。
J Cell Mol Med. 2016 May;20(5):864-73. doi: 10.1111/jcmm.12770. Epub 2016 Jan 28.
4
Extracellular vesicles carrying miR-193a derived from mesenchymal stem cells impede cell proliferation, migration and invasion of colon cancer by downregulating FAK.外泌体携带间充质干细胞来源的 miR-193a 通过下调 FAK 抑制结肠癌细胞增殖、迁移和侵袭。
Exp Cell Res. 2020 Sep 15;394(2):112144. doi: 10.1016/j.yexcr.2020.112144. Epub 2020 Jun 12.
5
MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression.MicroRNA-543 通过靶向 FAK 和 TWIST1 的表达抑制子宫内膜癌细胞的致癌性。
Arch Gynecol Obstet. 2014 Sep;290(3):533-41. doi: 10.1007/s00404-014-3219-3. Epub 2014 Apr 4.
6
MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.微小RNA-340通过靶向Wnt信号通路抑制乳腺癌细胞的迁移、侵袭和转移。
Tumour Biol. 2016 Jul;37(7):8993-9000. doi: 10.1007/s13277-015-4513-9. Epub 2016 Jan 12.
7
MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.MicroRNA-506 通过下调 LHX2 抑制 Wnt/β-catenin 信号通路抑制鼻咽癌的肿瘤生长和转移。
J Exp Clin Cancer Res. 2019 Feb 21;38(1):97. doi: 10.1186/s13046-019-1023-4.
8
miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.miR-448 通过直接靶向 E-钙黏蛋白抑制因子 ZEB1/2 抑制乳腺癌细胞的上皮-间充质转化。
Exp Biol Med (Maywood). 2018 Mar;243(5):473-480. doi: 10.1177/1535370218754848. Epub 2018 Jan 25.
9
miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.miR-190 通过调节 TGF-β 诱导的上皮间质转化抑制乳腺癌转移。
Mol Cancer. 2018 Mar 6;17(1):70. doi: 10.1186/s12943-018-0818-9.
10
MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.MicroRNA-30a 通过下调波形蛋白表达抑制细胞迁移和侵袭,是乳腺癌的潜在预后标志物。
Breast Cancer Res Treat. 2012 Aug;134(3):1081-93. doi: 10.1007/s10549-012-2034-4. Epub 2012 Apr 4.

引用本文的文献

1
MiR-7 inhibits progression of glioblastoma by impairing autophagy resolution, energy metabolism and ECM remodeling.微小RNA-7通过损害自噬清除、能量代谢和细胞外基质重塑来抑制胶质母细胞瘤的进展。
J Exp Clin Cancer Res. 2025 Aug 14;44(1):237. doi: 10.1186/s13046-025-03504-6.
2
miR-7-5p and Importin-7 Regulate the p53 Dynamics and Stability in Malignant and Benign Thyroid Cells.miR-7-5p与输入蛋白7调节恶性和良性甲状腺细胞中p53的动力学及稳定性
Int J Mol Sci. 2025 Jun 17;26(12):5813. doi: 10.3390/ijms26125813.
3
Identification of TIMP1-induced dysregulation of epithelial-mesenchymal transition as a key pathway in inflammatory bowel disease and small intestinal neuroendocrine tumors shared pathogenesis.

本文引用的文献

1
MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression.微小 RNA-7 通过靶向黏着斑激酶表达调控脑胶质瘤细胞侵袭。
Chin Med J (Engl). 2011 Sep;124(17):2616-21.
2
MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells.微小 RNA-7 在舌鳞癌细胞中靶向 IGF1R(胰岛素样生长因子 1 受体)。
Biochem J. 2010 Nov 15;432(1):199-205. doi: 10.1042/BJ20100859.
3
A MicroRNA targeting dicer for metastasis control.一种针对 Dicer 的 microRNA 用于转移控制。
鉴定基质金属蛋白酶组织抑制因子1(TIMP1)诱导的上皮-间质转化失调作为炎症性肠病和小肠神经内分泌肿瘤共同发病机制中的关键途径。
Front Genet. 2024 Aug 21;15:1376123. doi: 10.3389/fgene.2024.1376123. eCollection 2024.
4
The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives.基于微小RNA的方法在胶质母细胞瘤中的潜力:当前进展与未来展望的最新情况
Curr Res Pharmacol Drug Discov. 2024 Jun 29;7:100193. doi: 10.1016/j.crphar.2024.100193. eCollection 2024.
5
STR mutations on chromosome 15q cause thyrotropin resistance by activating a primate-specific enhancer of MIR7-2/MIR1179.15q 染色体上的 STR 突变通过激活灵长类特有的 MIR7-2/MIR1179 增强子导致促甲状腺素抵抗。
Nat Genet. 2024 May;56(5):877-888. doi: 10.1038/s41588-024-01717-7. Epub 2024 May 7.
6
Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions.非编码RNA作为实体瘤中受体酪氨酸激酶信号传导的潜在治疗靶点:现状与未来方向
Cancer Cell Int. 2024 Jan 10;24(1):26. doi: 10.1186/s12935-023-03203-2.
7
Expression of pY397-FAK and Its miR Regulators Drive Dedifferentiation in the Thyroid Neoplasia Spectrum.pY397-FAK 的表达及其 miR 调控因子驱动甲状腺肿瘤谱中的去分化。
Cells. 2023 Jun 26;12(13):1721. doi: 10.3390/cells12131721.
8
circRNAs in drug resistance of breast cancer.环状 RNA 在乳腺癌耐药中的作用。
Oncol Res. 2023 Jan 31;30(4):157-172. doi: 10.32604/or.2022.027547. eCollection 2022.
9
Therapeutic and diagnostic applications of exosomal circRNAs in breast cancer.外泌体 circRNAs 在乳腺癌中的治疗和诊断应用。
Funct Integr Genomics. 2023 May 27;23(2):184. doi: 10.1007/s10142-023-01083-3.
10
Genetic variations in tumor-suppressor miRNA-encoding genes and their target genes: focus on breast cancer development and possible therapeutic strategies.肿瘤抑制 miRNA 编码基因及其靶基因的遗传变异:聚焦于乳腺癌的发生发展和可能的治疗策略。
Clin Transl Oncol. 2024 Jan;26(1):1-15. doi: 10.1007/s12094-023-03176-8. Epub 2023 Apr 24.
Cell. 2010 Jun 25;141(7):1195-207. doi: 10.1016/j.cell.2010.05.017.
4
Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis.同时抑制整合素 α5、根蛋白和 RhoA 可模拟 miR-31 对转移的影响。
Cancer Res. 2010 Jun 15;70(12):5147-54. doi: 10.1158/0008-5472.CAN-10-0410. Epub 2010 Jun 8.
5
Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA.8q24.3 染色体上 miR-151 的获得通过下调 RhoGDIA 促进肿瘤细胞迁移和扩散。
Nat Cell Biol. 2010 Apr;12(4):390-9. doi: 10.1038/ncb2039. Epub 2010 Mar 21.
6
MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma.microRNA-30d 通过靶向调控 Galphai2 促进肝癌的侵袭和转移。
Hepatology. 2010 Mar;51(3):846-56. doi: 10.1002/hep.23443.
7
Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.微小 RNA-29 对肝癌细胞凋亡、致瘤性和预后的影响。
Hepatology. 2010 Mar;51(3):836-45. doi: 10.1002/hep.23380.
8
Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis.黏着斑激酶:乳腺癌起始、进展和转移的重要决定因素。
Cancer Lett. 2010 Mar 28;289(2):127-39. doi: 10.1016/j.canlet.2009.07.005. Epub 2009 Jul 29.
9
A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.一种具有多效性作用的微小RNA,即miR-31,可抑制乳腺癌转移。
Cell. 2009 Jun 12;137(6):1032-46. doi: 10.1016/j.cell.2009.03.047.
10
MicroRNAs: target recognition and regulatory functions.微小RNA:靶标识别与调控功能
Cell. 2009 Jan 23;136(2):215-33. doi: 10.1016/j.cell.2009.01.002.